Session-aware quotes · provider delays vary · Not financial advice
NeutralLOW severityTech & AI19d ago

Amgen outlines raised 2026 guidance of $38.2B-$39.4B revenue and $22.30-$23.50 non-GAAP EPS as CFO transition nears

Reported by Seeking Alpha · seekingalpha.com · August 5, 2026

$AMGN
Neutral read

What the tape says

What to watch: Amgen Inc. (AMGN) raised guidance toward $38 — confirm the raise reflects durable demand, not a one-time item.

Amount
$38.2 billion
Amount
$39.4 billion
Amount
$22.30
Amount
$23.50

Market reaction today: $AMGN +1.03%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.

Your read

Discussion

No one has weighed in yet. Start the discussion on this story.

More coverage on these names

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.